Daya Investor Circle: Inside the Round of Omaia & TrialMe
Join us for an exclusive investor-focused evening with two of Daya Ventures’ most high-potential startups currently raising WISE rounds — Omaia and TrialMe.
Both companies are accepting early investors on strong terms, with WISE financing that is designed to unlock leveraged seed loans, multiplying the impact of each ticket.
Whether you’re an experienced angel or a new investor actively looking to make your first early-stage investment, this session will give you:
✅ A clear understanding of each startup
✅ A transparent walk-through of the WISE terms
✅ Space to ask questions directly to the founders
✅ Potential opportunities to invest individually or join a syndicate
What You’ll Hear on Stage
🌸 Omaia (Maternal Mental Health, Digital Therapeutics)
A rapidly growing femtech startup addressing the maternal mental health crisis — affecting 1 in 4 pregnant women annually.
Omaia is co-creating a clinical-grade digital program with midwives and psychologists to reduce fear, anxiety, and birth complications.
With strong insurer demand and a €1.5B global market, Omaia is building a scalable preventive-care solution with significant cost-saving potential.
The team will present their traction, LOIs, roadmap, and WISE terms.
🧬 TrialMe (AI-driven Clinical Trial Recruitment for Women)
TrialMe is closing the gender gap in medical research by making it easy for women to join clinical trials that fit their lives.
The platform addresses recruitment inefficiencies that lead most trials to miss timelines or fail due to low enrollment — a costly, persistent problem for sponsors.
With a confirmed 200+ participant pilot kicking off in early 2026 and strong regulatory momentum behind diversity and decentralised trials, TrialMe is entering a fast-growing market at exactly the right moment.
The founders will walk through their raise, terms, and how the WISE structure supports rapid commercial validation.
Why This Is an Exceptional Early-Stage Opportunity
WISE rounds paired with government-backed seed loans mean:
💸 Investor capital is amplified
📉 Lower early-stage risk
🚀 Faster milestones and commercial validation
🤝 Lead investors already committed — both rounds are partially filled and now open for additional investors to complete the raise.
Investors may join directly or express interest in participating through a syndicate.
Who Should Attend
Angels and early-stage investors (Nordics, UK, EU, global)
First-time investors who are serious about deploying capital
Family offices and microfund GPs exploring femtech, digital health, or AI in healthcare
Investors seeking dealflow that offers strong early entry terms + loan leverage
What to Expect
✨ Short pitches
✨ Deep-dive into WISE terms
✨ Live Q&A
✨ A brief overview from Daya Ventures on our venture studio model and why these startups are positioned to win
✨ Optional investor matching following the event
Access
This is a small-format investor night. Please apply to join to receive the link and further event details.